font size
Sign in


Breaking through the Sequencing Bottleneck

Podcast: July 28, 2014

The rapid decline in the cost of genome sequencing is creating an information technology bottleneck as servers designed for general purposes have proven a bit clunky at assembling and analyzing the output from sequencers. Edico Genome thinks it has an answer with its DRAGEN Bio-IT Processor, designed specifically for processing genomic data. We spoke to Pieter van Rooyen, CEO of Edico about tackling the computing bottleneck, how the company plans to use the $10 million in funding it just raised, and what the implications of a dramatic reduction in time and cost will have on how sequencing is used. Read More
Todays Stories
Podcast The Changing Patent Landscape for Genome 2.0

Gareth Williams, partner with Marks & Clerk, discusses his firm's new report on patents related to personalized medicine, sequencing, and synthetic biology; where the sources of innovation are today; and the changing landscape for intellectual property.

By the numbers Sage Therapeutics Scores $90M in Upsized IPO

At a time when many biotech stocks fell on Federal Reserve Chairwoman Janet Yellen’s comments that the sector was overvalued, Sage Therapeutics raised $90 million in an upsized initial public offering at the top of its target range. After two other biotechs priced discounted offerings, its strong market debut stirred hopes that investor appetite for biotech IPOs had not waned.